Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 1 to 20 of 184

1.

Visually Evoked 3-5 Hz Membrane Potential Oscillations Reduce the Responsiveness of Visual Cortex Neurons in Awake Behaving Mice.

Einstein MC, Polack PO, Tran DT, Golshani P.

J Neurosci. 2017 May 17;37(20):5084-5098. doi: 10.1523/JNEUROSCI.3868-16.2017. Epub 2017 Apr 21.

PMID:
28432140
2.

SurePath Specimens Versus ThinPrep Specimen Types on the COBAS 4800 Platform: High-Risk HPV Status and Cytology Correlation in an Ethnically Diverse Bronx Population.

Naeem RC, Goldstein DY, Einstein MH, Ramos Rivera G, Schlesinger K, Khader SN, Suhrland M, Fox AS.

Lab Med. 2017 Mar 30. doi: 10.1093/labmed/lmx019. [Epub ahead of print]

PMID:
28379422
3.

Integrated genomic and molecular characterization of cervical cancer.

Cancer Genome Atlas Research Network; Albert Einstein College of Medicine; Analytical Biological Services; Barretos Cancer Hospital; Baylor College of Medicine; Beckman Research Institute of City of Hope; Buck Institute for Research on Aging; Canada's Michael Smith Genome Sciences Centre; Harvard Medical School; Helen F. Graham Cancer Center &Research Institute at Christiana Care Health Services; HudsonAlpha Institute for Biotechnology; ILSbio, LLC; Indiana University School of Medicine; Institute of Human Virology; Institute for Systems Biology; International Genomics Consortium; Leidos Biomedical; Massachusetts General Hospital; McDonnell Genome Institute at Washington University; Medical College of Wisconsin; Medical University of South Carolina; Memorial Sloan Kettering Cancer Center; Montefiore Medical Center; NantOmics; National Cancer Institute; National Hospital, Abuja, Nigeria; National Human Genome Research Institute; National Institute of Environmental Health Sciences; National Institute on Deafness &Other Communication Disorders; Ontario Tumour Bank, London Health Sciences Centre; Ontario Tumour Bank, Ontario Institute for Cancer Research; Ontario Tumour Bank, The Ottawa Hospital; Oregon Health &Science University; Samuel Oschin Comprehensive Cancer Institute, Cedars-Sinai Medical Center; SRA International; St Joseph's Candler Health System; Eli &Edythe L. Broad Institute of Massachusetts Institute of Technology &Harvard University; Research Institute at Nationwide Children's Hospital; Sidney Kimmel Comprehensive Cancer Center at Johns Hopkins University; University of Bergen; University of Texas MD Anderson Cancer Center; University of Abuja Teaching Hospital; University of Alabama at Birmingham; University of California, Irvine; University of California Santa Cruz; University of Kansas Medical Center; University of Lausanne; University of New Mexico Health Sciences Center; University of North Carolina at Chapel Hill; University of Oklahoma Health Sciences Center; University of Pittsburgh; University of São Paulo, Ribeir ão Preto Medical School; University of Southern California; University of Washington; University of Wisconsin School of Medicine &Public Health; Van Andel Research Institute; Washington University in St Louis.

Nature. 2017 Mar 16;543(7645):378-384. doi: 10.1038/nature21386. Epub 2017 Jan 23.

4.

Eurogin 2016 Roadmap: how HPV knowledge is changing screening practice.

Wentzensen N, Arbyn M, Berkhof J, Bower M, Canfell K, Einstein M, Farley C, Monsonego J, Franceschi S.

Int J Cancer. 2017 May 15;140(10):2192-2200. doi: 10.1002/ijc.30579. Epub 2017 Jan 11. Review.

PMID:
28006858
5.

Electronic patient-reported outcomes from home in patients recovering from major gynecologic cancer surgery: A prospective study measuring symptoms and health-related quality of life.

Cowan RA, Suidan RS, Andikyan V, Rezk YA, Einstein MH, Chang K, Carter J, Zivanovic O, Jewell EJ, Abu-Rustum NR, Basch E, Chi DS.

Gynecol Oncol. 2016 Nov;143(2):362-366. doi: 10.1016/j.ygyno.2016.08.335. Epub 2016 Sep 13.

PMID:
27637366
6.

In vitro inhibition of human papillomavirus following use of a carrageenan-containing vaginal gel.

Novetsky AP, Keller MJ, Gradissimo A, Chen Z, Morgan SL, Xue X, Strickler HD, Fernández-Romero JA, Burk R, Einstein MH.

Gynecol Oncol. 2016 Nov;143(2):313-318. doi: 10.1016/j.ygyno.2016.09.003. Epub 2016 Sep 10.

PMID:
27625046
7.

A polycomb-mediated epigenetic field defect precedes invasive cervical carcinoma.

Wijetunga NA, Ben-Dayan M, Tozour J, Burk RD, Schlecht NF, Einstein MH, Greally JM.

Oncotarget. 2016 Sep 20;7(38):62133-62143. doi: 10.18632/oncotarget.11390.

8.

Novel epigenetic changes in CDKN2A are associated with progression of cervical intraepithelial neoplasia.

Wijetunga NA, Belbin TJ, Burk RD, Whitney K, Abadi M, Greally JM, Einstein MH, Schlecht NF.

Gynecol Oncol. 2016 Sep;142(3):566-73. doi: 10.1016/j.ygyno.2016.07.006. Epub 2016 Jul 9.

9.

Insulin/IGF and sex hormone axes in human endometrium and associations with endometrial cancer risk factors.

Merritt MA, Strickler HD, Einstein MH, Yang HP, Sherman ME, Wentzensen N, Brouwer-Visser J, Cossio MJ, Whitney KD, Yu H, Gunter MJ, Huang GS.

Cancer Causes Control. 2016 Jun;27(6):737-48. doi: 10.1007/s10552-016-0751-4. Epub 2016 Apr 28.

10.

Current therapeutic vaccination and immunotherapy strategies for HPV-related diseases.

Skeate JG, Woodham AW, Einstein MH, Da Silva DM, Kast WM.

Hum Vaccin Immunother. 2016 Jun 2;12(6):1418-29. doi: 10.1080/21645515.2015.1136039. Epub 2016 Feb 2.

11.

Association of High-Risk Human Papillomavirus with Genital Tract Mucosal Immune Factors in HIV-Infected Women.

Buckley N, Huber A, Lo Y, Castle PE, Kemal K, Burk RD, Strickler HD, Einstein MH, Young M, Anastos K, Herold BC.

Am J Reprod Immunol. 2016 Feb;75(2):146-54. doi: 10.1111/aji.12461. Epub 2015 Dec 18.

12.

Menopause and Cancers.

Einstein MH, Levine NF, Nevadunsky NS.

Endocrinol Metab Clin North Am. 2015 Sep;44(3):603-17. doi: 10.1016/j.ecl.2015.05.012. Epub 2015 Jun 23. Review.

PMID:
26316246
13.

Association Between Statin Use and Endometrial Cancer Survival.

Nevadunsky NS, Van Arsdale A, Strickler HD, Spoozak LA, Moadel A, Kaur G, Girda E, Goldberg GL, Einstein MH.

Obstet Gynecol. 2015 Jul;126(1):144-50. doi: 10.1097/AOG.0000000000000926.

PMID:
26241267
14.

Screening for Anal Cancer in Women.

Moscicki AB, Darragh TM, Berry-Lawhorn JM, Roberts JM, Khan MJ, Boardman LA, Chiao E, Einstein MH, Goldstone SE, Jay N, Likes WM, Stier EA, Welton ML, Wiley DJ, Palefsky JM.

J Low Genit Tract Dis. 2015 Jul;19(3 Suppl 1):S27-42. doi: 10.1097/LGT.0000000000000117. Review.

15.

Degradation of Human PDZ-Proteins by Human Alphapapillomaviruses Represents an Evolutionary Adaptation to a Novel Cellular Niche.

Van Doorslaer K, DeSalle R, Einstein MH, Burk RD.

PLoS Pathog. 2015 Jun 18;11(6):e1004980. doi: 10.1371/journal.ppat.1004980. eCollection 2015 Jun.

16.

Physical activity for an ethnically diverse sample of endometrial cancer survivors: a needs assessment and pilot intervention.

Rossi A, Moadel-Robblee A, Garber CE, Kuo D, Goldberg G, Einstein M, Nevadunsky N.

J Gynecol Oncol. 2015 Apr;26(2):141-7. doi: 10.3802/jgo.2015.26.2.141.

17.

Decentralizing Maternity Services to Increase Skilled Attendance at Birth and Antenatal Care Utilization in Rural Rwanda: A Prospective Cohort Study.

Nathan LM, Shi Q, Plewniak K, Zhang C, Nsabimana D, Sklar M, Mutimura E, Merkatz IR, Einstein MH, Anastos K.

Matern Child Health J. 2015 Sep;19(9):1949-55. doi: 10.1007/s10995-015-1702-5.

18.

Use of primary high-risk human papillomavirus testing for cervical cancer screening: interim clinical guidance.

Huh WK, Ault KA, Chelmow D, Davey DD, Goulart RA, Garcia FA, Kinney WK, Massad LS, Mayeaux EJ, Saslow D, Schiffman M, Wentzensen N, Lawson HW, Einstein MH.

Gynecol Oncol. 2015 Feb;136(2):178-82. doi: 10.1016/j.ygyno.2014.12.022. Epub 2015 Jan 8.

PMID:
25579107
19.

Use of primary high-risk human papillomavirus testing for cervical cancer screening: interim clinical guidance.

Huh WK, Ault KA, Chelmow D, Davey DD, Goulart RA, Garcia FA, Kinney WK, Massad LS, Mayeaux EJ, Saslow D, Schiffman M, Wentzensen N, Lawson HW, Einstein MH.

J Low Genit Tract Dis. 2015 Apr;19(2):91-6. doi: 10.1097/LGT.0000000000000103.

PMID:
25574659
20.

Use of primary high-risk human papillomavirus testing for cervical cancer screening: interim clinical guidance.

Huh WK, Ault KA, Chelmow D, Davey DD, Goulart RA, Garcia FA, Kinney WK, Massad LS, Mayeaux EJ, Saslow D, Schiffman M, Wentzensen N, Lawson HW, Einstein MH.

Obstet Gynecol. 2015 Feb;125(2):330-7. doi: 10.1097/AOG.0000000000000669.

PMID:
25569009

Supplemental Content

Loading ...
Support Center